Export 2638 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
J. Bolaños-Meade, Reshef, R., Fraser, R., Fei, M., Abhyankar, S., Al-Kadhimi, Z., Alousi, A. M., Antin, J. H., Arai, S., Bickett, K., Bin Chen, Y. -, Damon, L. E., Efebera, Y. A., Geller, N. L., Giralt, S. A., Hari, P., Holtan, S. G., Horowitz, M. M., Jacobsohn, D. A., Jones, R. J., Liesveld, J. L., Logan, B. R., MacMillan, M. L., Mielcarek, M., Noel, P., Pidala, J., Porter, D. L., Pusic, I., Sobecks, R., Solomon, S. R., Weisdorf, D. J., Wu, J., Pasquini, M. C., and Koreth, J., Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with, Lancet Haematol, vol. 6, no. 3, pp. e132-e143, 2019.
K. M. Keppler-Noreuil, Lozier, J., Oden, N., Taneja, A., Burton-Akright, J., Sapp, J. C., and Biesecker, L. G., Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome., Am J Med Genet C Semin Med Genet, vol. 181, no. 4, pp. 571-581, 2019.
C. S Johnston, Elm, J. J., J Easton, D., Farrant, M., Barsan, W. G., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., Zurita, K. G., Albers, G. W., Cucchiara, B. L., Kleindorfer, D. O., Lutsep, H. L., Pearson, C., Sethi, P., and Vora, N., Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke., Circulation, vol. 140, no. 8, pp. 658-664, 2019.
P. Szabolcs, Mendizabal, A., Wilfret, D., Reese, M., Vinesette, R., Page, K., Parikh, S., and Kurtzberg, J., Time Sensitive Parameters of Immune Reconstitution Measured Between Day 100 and 1 Year Predict Survival After Unrelated Cord Blood Transplant (UCBT): The Dynamic Impact of Dendritic Cells, Tregs, and Thymic Recovery, presented at the 2011, Honolulu, HI, 2011, vol. 17 No 2 Su, p. S229.
, Wilfret, D., Reese, M., Vinesett, R., Page, K., Parikh, S. H., and Kurtzberg, J., Time Sensitive Parameters of Immune Reconstitution Measured Between Day 100 and 1 Year Predict Survival After Unrelated Cord Blood Transplant (UCBT): The Dynamic Impact of Dendritic Cells, Tregs, and Thymic Recovery., in European Society of Hematology World Cord Blood Congress, Marseille, 2010.
C. J. Nobles, Schisterman, E. F., Ha, S., Louis, G. M. Buck, Sherman, S., and Mendola, P., Time-varying cycle average and daily variation in ambient air pollution and fecundability., Hum Reprod, vol. 33, no. 1, pp. 166-176, 2018.
D. M. Stablein, Nolph, K. D., and Lindblad, A. S., Timing and characteristics of multiple peritonitis episodes: a report of the National CAPD Registry., Am J Kidney Dis, vol. 14, no. 1, pp. 44-9, 1989.
D. L. Phelps, Oden, N. L., Cole, C., Wood, N. E., Young, T. L., and Brozanski, B. S., Timing of retinopathy of prematurity (ROP) events: screening implications, 2000.
A. Liu, Sicherer, S., Schiltz, A., Henning, A., Stablein, D., Wood, R., Burks, A., Jones, S., Fleischer, D., Leung, D., Shreffler, W., Lindblad, R., Mayer, L., and Sampson, H., Toll-like Receptor Polymorphisms in Infants With Likely Milk/Egg Allergy: Consortium for Food Allergy Research (CoFAR), in Annual Meeting of the American Academy of Allergy, Asthma, and Immunology, Phoenix, AZ, 2010.
A. Liu, Sicherer, S., Schiltz, A., Henning, A., Stablein, D., Wood, R., Burks, A., Jones, S., Fleischer, D., Leung, D., Shreffler, W., Lindblad, R., Mayer, L., and Sampson, H., Toll-like Receptor Polymorphisms in Infants With Likely Milk/Egg Allergy: Consortium for Food Allergy Research (CoFAR)., New Orleans LA: , 2009.
H. M. El Sahly, Atmar, R. L., Sendra, E., Wegel, A., and Keitel, W. A., Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults., J Infect Dis, vol. Online Ahead of Print, 2021.
, Mendizabal, A., Wease, S., Carter, S., Gentry, T., Balber, A., and Kurtzberg, J., Total Colony-Forming Units Are a Strong, Independent Predictor of Neutrophil and Platelet Engraftment After Unrelated Umbilical Cord Blood Transplantation: A Single-Center Analysis of 435 Cord Blood Transplants, Biol Blood Marrow Transplant, vol. 17, pp. 1362-1374, 2011.
K. M. Page, Zhang, L., Mendizabal, A., Wease, S., Carter, S., Gentry, T., Balber, A. E., and Kurtzberg, J., Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants., Biol Blood Marrow Transplant, vol. 17, no. 9, pp. 1362-74, 2011.
A. F. Holtyn, Bosworth, E., Marsch, L. A., McLeman, B., Meier, A., Saunders, E. C., Ertin, E., Ullah, M. Azim, Samiei, S. Alan, Hossain, M., Kumar, S., Preston, K. L., Vahabzadeh, M., Shmueli-Blumberg, D., Collins, J., McCormack, J., and Ghitza, U. E., Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology., Contemp Clin Trials Commun, vol. 15, p. 100392, 2019.
P. R. Thomas, Lindblad, A. S., Stablein, D. M., Knowlton, A. H., Bruckner, H. W., Childs, D. S., and Mittelman, A., Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum., Cancer, vol. 57, no. 6, pp. 1130-4, 1986.
G. Sharma, Van Veldhuisen, P., and Allen, C. A., Tracking and Monitoring Trial Progress in NIDA CTN Studies, in NIH Workshop on Enrollment and Retention of Participants in NIH-funded Clinical Trials, Bethesda, MD, 2014.
S. Schenning, McBee, W. L., Clemons, T. E., Chew, E. Y., and SanGiovanni, J. P., Tracking of regulatory documents in a large clinical trial, The Age-Related Eye Disease Study 2, in Society for Clinical Trials, Miami, FL, 2012.
E. Shemesh, Duncan, S., Anand, R., Shneider, B. L., Alonso, E. M., Mazariegos, G. V., Venick, R. S., Annunziato, R. A., and Bucuvalas, J. C., Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort., Liver Transpl, vol. 24, no. 1, pp. 80-88, 2018.
R. Kosoy, Agashe, C., Grishin, A., Leung, D. Y., Wood, R. A., Sicherer, S. H., Jones, S. M., A Burks, W., Davidson, W. F., Lindblad, R. W., Dawson, P., Merad, M., Kidd, B. A., Dudley, J. T., Sampson, H. A., and M Berin, C., Transcriptional Profiling of Egg Allergy and Relationship to Disease Phenotype., PLoS One, vol. 11, no. 10, p. e0163831, 2016.
J. B. Goll, Li, S., Edwards, J. L., Bosinger, S. E., Jensen, T. L., Wang, Y., Hooper, W. F., Gelber, C. E., Sanders, K. L., Anderson, E. J., Rouphael, N., Natrajan, M. S., Johnson, R. A., Sanz, P., Hoft, D., and Mulligan, M. J., Transcriptomic and Metabolic Responses to a Live-Attenuated Vaccine., Vaccines (Basel), vol. 8, no. 3, 2020.
A. W. Heldman, DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., ,, Da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., and Hare, J. M., Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial, JAMA, vol. 311, pp. 62-73, 2014.
C. Kim, King, D., Chamberlain, J., Clemons, T., and Brandt, D., Transitioning Paper to Electronic Case Report Forms Mid-Study From One Clinical Research Organization to Another, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
J. Alexander, Metze, T., Goodman, H., McIntosh, M., Zeng, L., Cardi, M., Austin, J., Goel, S., Safdar, S., Greenburg, N., and Woodle, E., Transplant Success and Immunodulating Diets, 2003.
W. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C., Cukras, C., Chew, E., Sadda, S., and Ferris, F., Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
W. T. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C. B., Cukras, C., Chew, E. Y., Sadda, S. V. R., and Ferris, F. L., Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial., Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.